AI Trend Insights
Evidence-led trend reports that connect public signals to practical tools and product decisions.
finance decision
REINSURANCE GROUP OF AMERICA INC Posts Higher Revenue and Net Income in period-ended-2026-06-30 Filing
REINSURANCE GROUP OF AMERICA INC filed the periodic report summarised below from its SEC evidence. Revenues was $13,131,000,000 for the six months ended June 30, 2026, up from $10,859,000,000 a year earlier. Net Income (Loss) Attributable to Parent was $792,000,000 for the six months ended June 30, 2026, up from $466,000,000 a year earlier. Earnings Per Share, Diluted was $11.99 per diluted share for the six months ended June 30, 2026, up from $6.97 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $3,439,000,000 for the six months ended June 30, 2026, up from $2,607,000,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$5,643,000,000 for the six months ended June 30, 2026, down from -$2,872,000,000 a year earlier.
finance decision
USANA HEALTH SCIENCES INC posts lower revenue and a profit-to-loss swing on both windows, partly cushioned by stronger operating cash
USANA HEALTH SCIENCES INC filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$13,867,000 for the six months ended July 4, 2026, down from $19,057,000 a year earlier, swinging from a prior-year profit to a loss. Operating Income (Loss) was -$6,122,000 for the six months ended July 4, 2026, down from $32,389,000 a year earlier, swinging from a prior-year profit to a loss. Earnings Per Share, Diluted was -$0.75 per diluted share for the six months ended July 4, 2026, down from $1.01 per diluted share a year earlier, swinging from a prior-year profit to a loss.
finance decision
Arena Group Swings to Loss as Revenue and Operating Profit Soften in Interim Filing
Arena Group Holdings, Inc. filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$2,834,000 for the six months ended June 30, 2026, down from $112,659,000 a year earlier, swinging from a prior-year profit to a loss. Earnings Per Share, Diluted was -$0.06 per diluted share for the six months ended June 30, 2026, down from $2.38 per diluted share a year earlier, swinging from a prior-year profit to a loss. Revenue from Contract with Customer, Excluding Assessed Tax was $42,589,000 for the six months ended June 30, 2026, down from $76,827,000 a year earlier. Operating Income (Loss) was $1,976,000 for the six months ended June 30, 2026, down from $23,774,000 a year earlier.
finance decision
CitroTech Inc. Interim Filing: Revenue Softens on Both Windows While Loss Narrows, Going-Concern Flag Carries Through
CitroTech Inc. filed the periodic report summarised below from its SEC evidence. Revenues was $625,581 for the six months ended June 30, 2026, down from $1,657,020 a year earlier. Net Income (Loss) Attributable to Parent was -$10,113,118 for the six months ended June 30, 2026, up from -$22,807,422 a year earlier. Operating Income (Loss) was -$7,941,295 for the six months ended June 30, 2026, down from -$6,476,094 a year earlier. Earnings Per Share, Diluted was -$0.5 per diluted share for the six months ended June 30, 2026, up from -$2.47 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $91,666 for the six months ended June 30, 2026, down from $3,645,234 a year earlier.
finance decision
Theriva Biologics Interim Filing Shows Loss-Persistent Profile With Narrower Year-Over-Year Reductions And Going-Concern Flag
Theriva Biologics, Inc. filed the periodic report summarised below from its SEC evidence. Operating Income (Loss) was -$5,422,000 for the six months ended June 30, 2026, up from -$17,549,000 a year earlier. Earnings Per Share, Diluted was -$0.12 per diluted share for the six months ended June 30, 2026, up from -$3.64 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $3,852,000 for the six months ended June 30, 2026, down from $9,883,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$3,000 for the six months ended June 30, 2026, up from -$16,000 a year earlier. Net Cash Provided by (Used in) Operating Activities was -$5,541,000 for the six months ended June 30, 2026, up from -$9,468,000 a year earlier.
finance decision
Fossil Group Second-Quarter period-ended-2026-07-04 Filing Shows Revenue Decline on Both Windows With Mixed Profitability Direction
Fossil Group, Inc. filed the periodic report summarised below from its SEC evidence. Revenue from Contract with Customer, Excluding Assessed Tax was $434,449,000 for the six months ended July 4, 2026, down from $453,681,000 a year earlier. Operating Income (Loss) was $15,249,000 for the six months ended July 4, 2026, up from $1,742,000 a year earlier. Earnings Per Share, Diluted was -$0.19 per diluted share for the six months ended July 4, 2026, up from -$0.37 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $12,745,000 for the six months ended July 4, 2026, up from $8,709,000 a year earlier. Net Cash Provided by (Used in) Investing Activities was $1,956,000 for the six months ended July 4, 2026, down from $20,937,000 a year earlier.
finance decision
Smaller Loss Persists Across Both Windows in Milestone Scientific Interim Filing
MILESTONE SCIENTIFIC INC. filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$1,899,185 for the six months ended June 30, 2026, up from -$3,477,696 a year earlier. Operating Income (Loss) was -$1,889,645 for the six months ended June 30, 2026, up from -$3,482,484 a year earlier. Earnings Per Share, Diluted was -$0.02 per diluted share for the six months ended June 30, 2026, up from -$0.04 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was $1,458,184 for the six months ended June 30, 2026, up from $794,305 a year earlier. Net Cash Provided by (Used in) Investing Activities was -$5,771 for the six months ended June 30, 2026, up from -$5,776 a year earlier.
finance decision
Heritage Global Posts Profit-to-Loss Swing on Softer Top Line; Bottom Line Flips Negative Across Both Reporting Windows
Heritage Global Inc. filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was -$15,171,000 for the six months ended June 30, 2026, down from $2,701,000 a year earlier, swinging from a prior-year profit to a loss. Operating Income (Loss) was -$19,903,000 for the six months ended June 30, 2026, down from $3,635,000 a year earlier, swinging from a prior-year profit to a loss. Earnings Per Share, Diluted was -$0.44 per diluted share for the six months ended June 30, 2026, down from $0.08 per diluted share a year earlier, swinging from a prior-year profit to a loss.
finance decision
ImmuCell Reports Higher Quarterly and Year-to-Date Revenue, Operating Income, Net Income, and Diluted EPS Versus Prior Year
IMMUCELL CORP /DE/ filed the periodic report summarised below from its SEC evidence. Revenue from Contract with Customer, Excluding Assessed Tax was $17,543,408 for the six months ended June 30, 2026, up from $14,512,054 a year earlier. Net Income (Loss) Attributable to Parent was $3,776,263 for the six months ended June 30, 2026, up from $1,948,863 a year earlier. Operating Income (Loss) was $3,904,250 for the six months ended June 30, 2026, up from $1,687,187 a year earlier. Earnings Per Share, Diluted was $0.41 per diluted share for the six months ended June 30, 2026, up from $0.22 per diluted share a year earlier. Net Cash Provided by (Used in) Financing Activities was -$637,559 for the six months ended June 30, 2026, down from -$480,095 a year earlier.
finance decision
Quantum X Labs Interim Print Swings to Net Profit While Top Line Softens and Operating Loss Deepens
QUANTUM X LABS INC. filed the periodic report summarised below from its SEC evidence. Net Income (Loss) Attributable to Parent was $1,880,000 for the six months ended June 30, 2026, up from -$15,326,000 a year earlier, swinging from a prior-year loss to a profit. Earnings Per Share, Diluted was $0.1 per diluted share for the six months ended June 30, 2026, up from -$2.42 per diluted share a year earlier, swinging from a prior-year loss to a profit. Revenues was $646,000 for the six months ended June 30, 2026, down from $899,000 a year earlier. Operating Income (Loss) was -$1,945,000 for the six months ended June 30, 2026, down from -$1,078,000 a year earlier.